Department of Radiology
Found 11 results
Filters: Author is Guo, Hong-Fen  [Clear All Filters]
2023
Chung SK, Vargas DBurnes, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B et al..  2023.  Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.. J Nucl Med. 64(9):1439-1445.
2022
Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Vargas DBurnes, Patel M, Xu H, Guo H-F et al..  2022.  Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.. Mol Cancer Ther. 21(1):125-137.
2021
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2021.  Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 32(2):394.
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Vargas DBurnes et al..  2021.  A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.. Clin Cancer Res. 27(2):532-541.
2020
Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2020.  An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 31(3):501-506.
Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DBurnes et al..  2020.  Alpha radioimmunotherapy using Ac-proteus-DOTA for solid tumors - safety at curative doses.. Theranostics. 10(25):11359-11375.
2018
Cheal SM, Xu H, Guo H-F, Patel M, Punzalan B, Fung EK, Lee S-G, Bell M, Singh M, Jungbluth AA et al..  2018.  Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.. Theranostics. 8(18):5106-5125.
2017
Cheal SM, Fung EK, Patel M, Xu H, Guo H-F, Zanzonico PB, Monette S, K Wittrup D, Cheung N-KV, Larson SM.  2017.  Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.. J Nucl Med. 58(11):1735-1742.
2016
Cheal SM, Xu H, Guo H-F, Lee S-G, Punzalan B, Chalasani S, Fung EK, Jungbluth A, Zanzonico PB, Carrasquillo JA et al..  2016.  Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.. Eur J Nucl Med Mol Imaging. 43(5):925-937.
2015
Ahmed M, Cheng M, Zhao Q, Goldgur Y, Cheal SM, Guo H-F, Larson SM, Cheung N-KV.  2015.  Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.. J Biol Chem. 290(50):30018-29.
2014
Cheal SM, Xu H, Guo H-F, Zanzonico PB, Larson SM, Cheung N-K.  2014.  Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.. Mol Cancer Ther. 13(7):1803-12.